Matinas BioPharma (MTNB) Misses Q3 EPS by 1c; Reports Cash and Cash Equivalents of $53.8M
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- S&P 500 futures steady after midterm rally; Nasdaq lags on chip weakness
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
| (NYSE: MTNB) | Delayed: 1.19 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.19 | 52 Week High | $2.01 | |||
| Open | $1.19 | 52 Week Low | $0.41 | |||
| Day High | $1.19 | P/E | N/A | |||
| Day Low | $1.19 | EPS | $0.00 | |||
| Volume | 949 | |||||
